Cardiff University has formed a drug discovery collaboration with Takeda Pharmaceutical Company Limited to identify new approaches for treating schizophrenia and other psychiatric disorders. The collaboration will combine Cardiff University’s large scale genomic data, and world class expertise in psychiatric genetics, genomics and neuroscience, with Takeda’s extensive drug discovery and clinical development capabilities. Professor Lawrence … Continue reading New approaches for treating psychiatric disorders